Business · 30/06/2023
FDA Releases Final Guidance on Chronic Rhinosinusitis Treatment Drugs
The FDA has released a final guidance to help pharmaceutical companies develop effective treatments for chronic rhinosinusitis with nasal polyps, addressing key aspects of trial design, safety, and effectiveness.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →